AEHR TEST SYSTEMS 8-K

What Happened

• Aehr Test Systems (AEHR) announced in an 8-K that on April 17, 2026 it fully utilized its previously announced at-the-market (ATM) equity offering program and completed sales of common stock generating aggregate gross proceeds of approximately $60.0 million. The shares were offered under the company’s effective Form S-3 registration statement and the prospectus supplement dated April 8, 2026.

Key Details

• Offering type: at-the-market equity offering (ATM).
• Gross proceeds: approximately $60.0 million.
• Completion date: April 17, 2026.
• Registered capacity: Form S-3 registered up to $100.0 million of securities (prospectus supplement dated April 8, 2026).

Why It Matters

• This financing increased Aehr’s cash resources, which can be used for operations, working capital, growth initiatives, or other corporate purposes. Because the company sold newly issued common stock, the transaction increases the number of shares outstanding and results in dilution to existing shareholders. Investors should note the raised capital and dilution effect when evaluating near-term liquidity, capital structure, and per-share metrics (e.g., EPS).